Every AI newsletter,Soochow Securities released a research report on August 29, stating that it maintains the buy rating of Aier Ophthalmology (300015.SZ, latest price: 47.05 yuan). The reasons for the rating mainly include: 1) The number of visits to the clinic has recovered rapidly, and the rapid development of refractive and optometry services; 2) The new ten-year strategic plan is advanced, and the ophthalmology medical network is continuously improved; 3) The medical research platform continues to be strengthened, and the “Technology Aier” strategy is promoted. . Risk warning: the risk of single hospital growth or less than expected; the risk of medical malpractice.
AI Comments: Aier Ophthalmology has received the attention of 13 brokerage research reports in the past month, bought 9 companies, increased holdings by one, and the average target price is 57 yuan, which is 9.95 yuan higher than the latest price of 47.05 yuan, and the target average price increase 21.15%.
Every Jing Toutiao (nbdtoutiao)——The Fed releases the Taper signal; the “Whale” enters the market with Bitcoin hitting 50,000; the first interest rate hike since South Korea’s epidemic; Ronaldo returns to Manchester United|One week of international finance
(Reporter Cai Ding)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. According to this operation, at your own risk.
Copyright Notice
1This article is the original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, extracting, copying or creating mirror images, etc., offenders must be investigated.
3Copyright cooperation telephone: 021-60900099.